Product Program year 2020 Source: CMS Open Payments

VenaSeal

Device EndoVenous Therapies

Open in the dashboard

General payments

$8,227,356

5,694 payments

Research payments

$309,344

30 payments

Through program year 2020, $8,227,356 in general payments and $309,344 in research payments were reported against VenaSeal (EndoVenous Therapies).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $220,043 1,893
2020 Research $230,324 20
2019 General $8,007,313 3,801
2019 Research $79,020 10

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic Vascular, Inc. $8,227,342 5,693 payments
  2. Covidien LP $14 1 payment
Top recipients General payments · program year 2020
  1. Robert Foster Interventional Cardiology · Birmingham, AL $15,368 7% · 13 payments
  2. Glenn Kline Surgery · Wyomissing, PA $13,700 6% · 26 payments
  3. Kathleen Gibson Vascular Surgery · Bellevue, WA $13,008 6% · 15 payments
  4. Leigh Ann Obanion Vascular Surgery · Fresno, CA $10,720 5% · 19 payments
  5. Andrew Jones Surgery · Bend, OR $8,113 4% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Vascular Surgery Surgery $79,351 36% · 238 practitioners
  2. Surgery $40,983 19% · 128 practitioners
  3. Interventional Cardiology Internal Medicine $33,771 15% · 99 practitioners
  4. Cardiovascular Disease Internal Medicine $18,286 8% · 132 practitioners
  5. Vascular & Interventional Radiology Radiology $14,090 6% · 88 practitioners

The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $29,739 14% · 109 recipients
  2. Pennsylvania $20,136 9% · 24 recipients
  3. New York $20,040 9% · 39 recipients
  4. Alabama $17,515 8% · 26 recipients
  5. Washington $16,879 8% · 41 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

5,694 general · 30 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record